Unicycive Therapeutics Net Debt Growth & History (UNCY)

Unicycive Therapeutics's net debt was −$29.1M for fiscal 2025.

View full Unicycive Therapeutics company overview

Unicycive Therapeutics annual net debt history

Unicycive Therapeutics annual net debt

Fiscal yearPeriod endedNet debtChangeGrowth
20252025-12-31−$29.1M−$3.6M
20242024-12-31−$25.5M−$16.6M
20232023-12-31−$8.9M−$8.6M
20222022-12-31−$300,000$16.0M
20212021-12-31−$16.3M

Unicycive Therapeutics net debt trends

Between the periods ended 2021-12-31 and 2025-12-31, Unicycive Therapeutics's net debt decreased from −$16.3M to −$29.1M, a change of −$12.8M. The latest reported quarter, Q2 2026, shows −$43.5M.

About the metric

What net debt means

Net debt compares a company’s interest-bearing debt with its cash and cash equivalents. Positive net debt means debt exceeds cash, while a negative value indicates the company has more cash than debt on this measure.

Calculation and source

How net debt is calculated

TickerStat calculates net debt as total interest-bearing debt minus cash and cash equivalents at the same reporting-period end. Short-term investments are not subtracted because they are not included in the standardized cash series. Fiscal periods can differ from calendar years, so exact period-end dates are included.

Review Unicycive Therapeutics source filings ↗

Community posts

It’s quiet here.

No posts about UNCY yet. Start the conversation.

Write the first post